Edwards Lifesciences Corporation (EW) Q3 2010 Earnings Results

Edwards Lifesciences Misses on EPS — Stock Down 2.2%

Edwards Lifesciences reported an EPS of $0.40, slightly missing expectations, which contributed to a 2.2% drop in stock price. The lack of revenue data and guidance may have left investors feeling uncertain. Management's focus on long-term growth and innovation suggests they are looking beyond current challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.40	N/A	-5.21%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the future. They acknowledged current challenges but emphasized their commitment to innovation.

Management expressed confidence in long-term growth despite short-term challenges.

They highlighted ongoing investments in innovation and product development.

Edwards Lifesciences Misses on EPS — Stock Down 2.2%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Misses on EPS — Stock Down 2.2%

Key numbers

Management commentary